Ismaheel O. Lawal - Concepedia

Author

Ismaheel O. Lawal

Also Known As

I Lawal, I O Lawal, I. Lawal, I. O. Lawal, IO Lawal, Imrana-Bakare Lawal, Ismaheel Lawal, Ismaheel O Lawal, Ismaheel O. LAWAL, Ismaheel O. Lawal

145

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

University of Pretoria Steve Biko Hospital Ghent University Hospital University of Ilorin University Medical Center Groningen

About

Ismaheel O. Lawal is an author at University of Pretoria specializing in oncology, medicine, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	409
2	Health Sciences	4	4	91
3	Engineering	1	1	13
4	Public Health	1	1	29
5	Biomedical Engineering	1	1	13

Ismaheel O. Lawal

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study Mike Sathekge, Frank Bruchertseifer, Otto Knoesen, European Journal of Nuclear Medicine and Molecular Imaging	2018	334
Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving <sup>225</sup>Ac-PSMA-617 Radioligand Therapy Mike Sathekge, Frank Bruchertseifer, Mariza Vorster, Journal of Nuclear Medicine	2019	191
Intraindividual Comparison of <sup>18</sup>F-PSMA-1007 and <sup>18</sup>F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot Study Frederik L. Giesel, Leon Will, Ismaheel O. Lawal, Journal of Nuclear Medicine	2017	173
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study Mike Sathekge, Ismaheel O. Lawal, Chandrasekhar Bal, The Lancet Oncology Retrospective StudyUrologyRadiation MedicineMedicineRadiopharmaceutical Therapy	2024	157
68Ga-PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli? Thabo Lengana, Ismaheel O. Lawal, Tebatso Boshomane, Clinical Genitourinary Cancer UrologyOncologic ImagingGenitourinary CancerMedicineFait Accompli	2018	119
mCRPC Patients Receiving <sup>225</sup>Ac-PSMA-617 Therapy in the Post–Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis Mike Sathekge, Frank Bruchertseifer, Mariza Vorster, Journal of Nuclear Medicine	2022	72
Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT Ismaheel O. Lawal, Alfred O. Ankrah, Neo P. Mokgoro, The Prostate	2017	71
Head-to-head Intra-individual Comparison of [68Ga]-FAPI and [18F]-FDG PET/CT in Patients with Bladder Cancer Emil Novruzov, Katharina Dendl, Honest Ndlovu, Molecular Imaging and Biology	2022	50
225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings Mike Sathekge, Frank Bruchertseifer, Mariza Vorster, European Journal of Nuclear Medicine and Molecular Imaging	2023	49
Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617 Mike Sathekge, Frank Bruchertseifer, Ismaheel O. Lawal, European Journal of Nuclear Medicine and Molecular Imaging UrologySurgical OncologyGenitourinary CancerMedicineNeurology	2019	47

Page 1